Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 30 September 2025
- Conf. stmt due
- 5 November 2027
- Last conf. stmt
- 22 October 2026
North West Cancer Research Trading Limited
- Incorporated
- 5 November 2012 (14 years)
- Previously known as
- Clatterbridge Cancer Research Limited (until 11 February 2020)This list may be incomplete. See all names on Companies House
- Industry
- Retail sale of other second-hand goods in stores (not incl. antiques) (47799)
- Directors
- David Edward Sanderson
- Accounts type
- Small
- Region
- North West
- Address
- Room G6 Liverpool Science Park131 Mount PleasantLiverpoolL3 5TF
Officers 5 active
Officer details are public data from the Companies House register.
Director · Appointed 22 August 2025
British
Born November 1962
Sanderson, David Edward
Director · Appointed 4 November 2022
British
Born May 1972 (54)
Director · Appointed 4 November 2022
Also at DMD 2019 Ltd (proposed for strike-off) · more companies
British
Born September 1977 (49)
Director · Appointed 4 November 2022
British
Born November 1981
Richards, Alastair David
Secretary · Appointed 20 April 2017
Officer history (9 former)
16 September 2026
Resigned Atherton-Tomlin, Hilary as Director
13 April 2026
Resigned Plunkett, Sharon Jean as Director
22 August 2025
4 November 2022
4 November 2022
4 November 2022
Appointed Plunkett, Sharon Jean as Director
4 November 2022
4 November 2022
Appointed Atherton-Tomlin, Hilary as Director
4 November 2022
4 November 2022
Appointed Sanderson, David Edward as Director
28 April 2022
28 April 2022
28 April 2022
28 April 2022
20 April 2017
20 April 2017
20 April 2017
Appointed Richards, Alastair David as Secretary
20 April 2017
Resigned Bagnall, Anthony Alan as Director
20 April 2017
20 April 2017
5 November 2012
Appointed Bagnall, Anthony Alan as Director
5 November 2012
5 November 2012
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Private Company Limited By Guarantee Exempt Under Section 60
Reg. no. 02165552
Group structure 3 companies
Ownership group derived from the Companies House PSC register
North West Cancer Research Events Ltd Owns 75–100% of shares
North West Cancer Research Trading Limited This company Owns 75–100% of shares
Financials
Figures from 2023 accounts. Newer accounts, made up to 30 September 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £1
Trend
Net Assets
Balance sheet detail
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fixed Assets | £0 | ||||
| Current Assets | £0 | ||||
| Creditors (< 1 year) | £0 | ||||
| Creditors (> 1 year) | £0 | ||||
| Net Current Assets | £0 | ||||
| Net Assets | £1 | £1 | £1 | £1 | £1 |
| Shareholder Funds | £1 | £1 | £1 | £1 | £1 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 26 October 2026 | Confirmation statement with no updates | 22 October 2026 | ||
| 9 August 2026 | Accounts for a small company | 30 September 2025 |
Some other companies at this address
Other companies in this industry
Wimborne
Wolverhampton
Billericay
Aston
Liverpool
Northampton
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →